We are live on ! Find out more
MGLN

Magellan Health Services, Inc.

Delisted

MGLN was delisted on the 3rd of January, 2022.

210 hedge funds and large institutions have $1.77B invested in Magellan Health Services, Inc. in 2018 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 88 increasing their positions, 73 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

108% more call options, than puts

Call options by funds: $4.71M | Put options by funds: $2.27M

21% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 73

8% less funds holding

Funds holding: 228210 (-18)

24% less capital invested

Capital invested by funds: $2.34B → $1.77B (-$573M)

39% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 41

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
210
Holders Change
-18
Holders Change %
-7.89%
% of All Funds
4.8%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
25
Increased
88
Reduced
73
Closed
41
Calls
$4.71M
Puts
$2.27M
Net Calls
+$2.44M
Net Calls Change
+$5.36M
Name Holding Trade Value Shares
Change
Change in
Stake
WAM
201
Wealthspire Advisors (Maryland)
Maryland
$4K +$724 +9 +17%
RCAG
202
Rehmann Capital Advisory Group
Michigan
$2.16K
AssetMark Inc
203
AssetMark Inc
California
$2K -$241 -3 -9%
TWA
204
TCI Wealth Advisors
Arizona
$1K -$644 -8 -40%
FGAM
205
Financial Gravity Asset Management
Texas
$1K -$241 -3 -27%
PCG
206
Private Capital Group
Connecticut
$1K
QCG
207
Quadrant Capital Group
Ohio
$1K
PFBT
208
Parkside Financial Bank & Trust
Missouri
$1K +$322 +4 +29%
O
209
OrbiMed
New York
-$24.1M -251,383 Closed
HRCM
210
Hood River Capital Management
Florida
-$19.9M -207,346 Closed
HAM
211
Hillcrest Asset Management
Texas
-$9.44M -98,361 Closed
BGIM
212
Brandywine Global Investment Management
Pennsylvania
-$6.43M -66,982 Closed
WG
213
Winton Group
United Kingdom
-$6.23M -64,934 Closed
Arrowstreet Capital
214
Arrowstreet Capital
Massachusetts
-$5.78M -60,205 Closed
HCM
215
Highbridge Capital Management
New York
-$4.34M -45,232 Closed
Mackenzie Financial
216
Mackenzie Financial
Ontario, Canada
-$3.71M -38,700 Closed
ACM
217
Altalis Capital Management
New York
-$3.15M -32,813 Closed
CIP
218
Convergence Investment Partners
Florida
-$1.9M -19,791 Closed
CIC
219
Cornercap Investment Counsel
Georgia
-$1.52M -15,830 Closed
SSA
220
Schonfeld Strategic Advisors
New York
-$1.44M -15,000 Closed
SAM
221
Shell Asset Management
Netherlands
-$1.17M -12,225 Closed
AIM
222
Assured Investment Management
New York
-$1.05M -10,915 Closed
Wellington Management Group
223
Wellington Management Group
Massachusetts
-$1.02M -10,678 Closed
Parallax Volatility Advisers
224
Parallax Volatility Advisers
California
-$988K -10,294 Closed
LCM
225
Laurion Capital Management
New York
-$757K -7,890 Closed

MGLN Hedge Fund Activity: Q3 2018 in Review

210 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Magellan Health Services, Inc. (MGLN) for Q3 2018, worth a combined $1.77B — down 24% from $2.34B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of MGLN and 25 opened new positions — a net loss of 16 holders — while 73 trimmed existing stakes and 88 added.

The largest buyer was Point72 Asset Management, adding an estimated $19.2M. The largest seller was OrbiMed, exiting entirely with an estimated $24.1M sold.

  • 210 institutional investors held Magellan Health Services, Inc. (MGLN) as of Q3 2018, down from 228 in Q2 2018.
  • Funds reported $1.77B of Magellan Health Services, Inc. stock for Q3 2018, down 24% quarter-over-quarter.
  • 25 funds opened new Magellan Health Services, Inc. positions in Q3 2018 and 41 closed out, a net change of -16 holders.
  • The largest Magellan Health Services, Inc. buyer in Q3 2018 was Point72 Asset Management, an estimated $19.2M added.
  • The largest Magellan Health Services, Inc. seller in Q3 2018 was OrbiMed, an estimated $24.1M sold.

Based on aggregated 13F filings for Q3 2018.